Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
4.110
-0.140 (-3.29%)
At close: May 13, 2025, 4:00 PM
4.160
+0.050 (1.22%)
Pre-market: May 14, 2025, 5:42 AM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2016 - 2018 |
| Hereditary Cancers | 327.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hereditary Cancers Growth | 7.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Prenatal | 151.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Prenatal Growth | 29.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmacogenomics | 138.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmacogenomics Growth | 8.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tumor Profiling | 135.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tumor Profiling Growth | 5.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Autoimmune | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Autoimmune Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical and Clinical Service | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2016 - 2018 |
| United States | 671.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 13.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World | 81.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World Growth | -6.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|